The Vietnam cancer vaccines market size reached USD 30.40 Million in 2024. Looking forward, the market is projected to reach USD 70.23 Million by 2033, exhibiting a growth rate (CAGR) of 9.75% during 2025-2033. The market is driven by the increasing prevalence of cancer cases, growing government healthcare investments, rising awareness about preventive healthcare measures, and the expanding adoption of advanced immunotherapy treatments. Vietnam's strengthening healthcare infrastructure and increased focus on cancer prevention programs are contributing to the Vietnam cancer vaccines market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 30.40 Million |
Market Forecast in 2033 | USD 70.23 Million |
Market Growth Rate 2025-2033 | 9.75% |
Advancing Therapeutic Cancer Vaccine Technologies
The Vietnam cancer vaccines market is experiencing significant momentum driven by breakthrough developments in therapeutic vaccine technologies, particularly mRNA platforms and personalized immunotherapy approaches. For instance, in May 2025, Vietnam's VNVC Vaccine Company partnered with the Russian Direct Investment Fund to access a potential mRNA cancer vaccine, announced during General Secretary To Lam's visit to Russia. The agreement includes technology transfer and local production, aiming to provide Vietnamese patients with advanced cancer treatments and promote high-tech biomedicine collaboration. These innovative treatment modalities are revolutionizing cancer care by training the immune system to recognize and attack specific cancer cells more effectively. Vietnam's healthcare sector is gradually adopting these advanced therapeutic approaches, supported by increasing collaboration with international pharmaceutical companies and research institutions. The emergence of dendritic cell vaccines, viral vector technologies, and antigen-adjuvant combinations is creating new treatment possibilities for Vietnamese cancer patients. Healthcare providers are investing in specialized infrastructure and training programs to implement these sophisticated treatment protocols. This technological advancement is particularly significant for addressing Vietnam's high cervical and liver cancer incidence rates.
Expanding Access Through Government Healthcare Initiatives
Vietnam's commitment to expanding healthcare access is significantly driving the Vietnam cancer vaccines market growth, with substantial government investments in public health infrastructure and cancer prevention programs. The Ministry of Health has been implementing comprehensive vaccination strategies as part of the National Cancer Control Program, focusing particularly on preventive vaccines for high-prevalence cancers like cervical cancer. Government-sponsored immunization programs are being expanded beyond traditional childhood vaccinations to include adult cancer prevention initiatives. The establishment of specialized cancer treatment centers across major cities is improving access to advanced vaccine therapies, particularly in Ho Chi Minh City, Hanoi, and Da Nang. Healthcare policy reforms are streamlining the approval and distribution processes for cancer vaccines, reducing bureaucratic barriers that previously limited patient access. Public awareness campaigns are being launched to educate citizens about cancer prevention and the importance of vaccination, particularly targeting high-risk populations. For instance, in August 2025, Vietnam's Ministry of Health launched a campaign, "For a Vietnam free from the burdens of HPV," to raise awareness about HPV-related diseases and cancers. The initiative aims to promote HPV vaccination and education across the country to reduce health risks. The healthcare sector's digitization initiatives are improving patient tracking and vaccine administration efficiency across the country.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on type, technology, indication, and end user.
Type Insights
The report has provided a detailed breakup and analysis of the market by type. This includes preventive cancer vaccines and therapeutic cancer vaccines.
Technology Insights
A detailed breakup and analysis of the market based on technology have also been provided in the report. This includes dendritic cells cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, viral vector and DNA cancer vaccines, and whole-cell cancer vaccines.
Indication Insights
The report has provided a detailed breakup and analysis of the market based on indication. This includes cervical cancer, prostate cancer, and others.
End User Insights
A detailed breakup and analysis of the market based on end user have also been provided in the report. This includes pediatrics and adults.
Regional Insights
The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Types Covered | Preventive Cancer Vaccines, Therapeutic Cancer Vaccines |
Technologies Covered | Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Viral Vector and DNA Cancer Vaccines, Whole-Cell Cancer Vaccines |
Indications Covered | Cervical Cancer, Prostate Cancer, Others |
End Users Covered | Pediatrics, Adults |
Regions Covered | Northern Vietnam, Central Vietnam, Southern Vietnam |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: